ReachMD

Be part of the knowledge.™

Oncology and Hematology

1961

LikeLikedUnlike

Episodes 1-15 of 536

- Jacob Sands, MD
  Peer
- Andrea B. McKee, MD
  Peer
4
Project Oncology®
Assessing Quality of Care: Implementing a Lung Screening Program
Assessing Quality of Care: Implementing a Lung Screening Program
- Jacob Sands, MD
  Peer
- Andrea B. McKee, MD
  Peer
3
Project Oncology®
Understanding Updates in Lung Cancer Screening
Understanding Updates in Lung Cancer Screening
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Adam Olsen, MS, PA-C
  Peer
0
GI Insights
Navigating the Intersection of Antithrombotic Therapy & GI Bleeding
Navigating the Intersection of Antithrombotic Therapy & GI Bleeding
- Paul Doghramji, MD
  Peer
- Tony Y. Hu, PhD
  Peer
0
Closing the Gaps in NSCLC
Current & Future Innovations in Lung Cancer Detection
Current & Future Innovations in Lung Cancer Detection
- Stephen Liu, MD
  Peer
1
Closing the Gaps in NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
- Paul Doghramji, MD
  Peer
- Tony Y. Hu, PhD
  Peer
0
Closing the Gaps in NSCLC
Investigating a Potential Serum Biomarker for Lung Cancer
Investigating a Potential Serum Biomarker for Lung Cancer
- Paul P. Doghramji, MD, FAAFP
  Peer
- Edward S. Kim, MD
  Peer
1
Closing the Gaps in NSCLC
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
- Edward S. Kim, MD
  Peer
0
Closing the Gaps in NSCLC
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
- Amit Bobby Mahajan, MD, FCCP, DAABIP
  Peer
0
Closing the Gaps in NSCLC
NSCLC State of the Union: Where We Are & Where We're Going
NSCLC State of the Union: Where We Are & Where We're Going
- Jennifer Caudle, DO
  Peer
- Stephen Liu, MD
  Peer
2
Closing the Gaps in NSCLC
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
- Hector O. Chapa, MD
  Peer
- Cameron Ayala
  Peer
1
Clinician's Roundtable
Living with Lymphedema: A Patient Perspective
Living with Lymphedema: A Patient Perspective
- Jacob Sands, MD
  Peer
- Aaron S. Mansfield, MD
  Peer
3
Project Oncology®
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
- Shannon L. Meeks, MD
  Peer
- Jonathan C. Roberts, MD
  Peer
2
CME/CE
Practical Guidance for Surveillance and Reporting in Hemophilia A
Practical Guidance for Surveillance and Reporting in Hemophilia A
0.25 credits

Programs 4/20/21

Segment Chapters

Playlist:

Recommended